Latest Insulet News & Updates

See the latest news and media coverage for Insulet. We track all announcements, press releases, and industry mentions in real time, all in one place.

Insulet

Maker of tubeless insulin delivery systems

insulet.com

Headquarters: Acton, United States
Founded year: 2000
Company type: Public company
Number of employees: 1,000–5,500

Last updated Today

Latest news about Insulet

In short: Insulet reported strong financial growth and product innovations while managing significant legal reversals and large-scale product recalls in 2026.

Company announcements

June 4 Insulet

Insulet reveals new data for Omnipod 6 and closed-loop

The STRIVE pivotal trial and EVOLUTION 3 feasibility study show improved glucose control with fewer boluses.

May 26 Insulet

Insulet initiates voluntary correction for certain Omnipod pods

The correction addresses a manufacturing issue that could cause insulin under-delivery, affecting approximately 7 million pods globally.

May 6 Insulet

Insulet reports Q1 2026 results

Revenue reaches $761.7M, up 33.9%; raises full-year guidance. Launches Omnipod 5 in Middle East, updates algorithm.

May 4 Insulet

Insulet enrolls first participant in EVOLVE study

The pivotal trial tests a fully closed-loop automated insulin delivery system for type 2 diabetes, aiming for FDA submission in 2027.

Media coverage

June 16 AD HOC NEWS

Insulet Stock (US45784P1012): Quarterly earnings and growth outlook in focus

Insulet is in focus as investors review its latest quarterly results, growth in its Omnipod insulin delivery franchise, and updated guidance under US-GAAP. The Nasdaq-listed...

June 16 JD Supra

Federal Circuit Holds That DTSA Statute of Limitations Starts Running When Plaintiff Has Enough Facts to Plead - Not Necessarily to 'Prove' - a DTSA Claim

We all should know the risks of rushing to file a trade secret misappropriation claim under the Defend Trade Secrets Act (DTSA) without...

June 12 Seeking Alpha

Insulet Corporation (PODD) Discusses Recent Product Recalls and Physician Community Response at ADA Meeting Transcript

Insulet Corporation ( PODD) Discusses Recent Product Recalls and Physician Community Response at ADA Meeting June 8, 2026 11:00 AM EDT Jeffrey Johnson - Robert...

June 11 GuruFocus

PODD Maintained by Truist Securities -- Price Target Lowered to

On October 24, 2023, Truist Securities maintained a 'Buy' rating on Insulet Corporation (PODD), with analyst Richard Newitter revising the price target down fro...

Never miss news about Insulet

Track Insulet and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Insulet competitors & trending companies

Browse news for competitors to Insulet and other trending companies.